Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study

Davie Wong, Titus Wong, Marc Romney, Victor Leung

Open source

DOI
10.1186/s12879-016-1564-5
Published
2016-05-23
Container
BMC Infectious Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

limited evidence Score 46/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-016-1564-5,
  title = {Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study},
  author = {Davie Wong and Titus Wong and Marc Romney and Victor Leung},
  year = {2016},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/s12879-016-1564-5},
  url = {https://doi.org/10.1186/s12879-016-1564-5}
}

RIS

TY  - JOUR
TI  - Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
AU  - Davie Wong
AU  - Titus Wong
AU  - Marc Romney
AU  - Victor Leung
PY  - 2016
JO  - BMC Infectious Diseases
DO  - 10.1186/s12879-016-1564-5
UR  - https://doi.org/10.1186/s12879-016-1564-5
ER  - 

APA

Wong, D., Wong, T., Romney, M., & Leung, V. (2016). Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-016-1564-5

Source records